Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease

Background:. Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to...

Full description

Bibliographic Details
Main Authors: Summer A. Beeson, BS, Daniel Neubauer, MD, Richard Calvo, PhD, Michael Sise, MD, Matthew Martin, MD, FACS, David S. Kauvar, MD, MPH, Chris M. Reid, MD
Format: Article
Language:English
Published: Wolters Kluwer 2023-01-01
Series:Plastic and Reconstructive Surgery, Global Open
Online Access:http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004727
_version_ 1797947130430619648
author Summer A. Beeson, BS
Daniel Neubauer, MD
Richard Calvo, PhD
Michael Sise, MD
Matthew Martin, MD, FACS
David S. Kauvar, MD, MPH
Chris M. Reid, MD
author_facet Summer A. Beeson, BS
Daniel Neubauer, MD
Richard Calvo, PhD
Michael Sise, MD
Matthew Martin, MD, FACS
David S. Kauvar, MD, MPH
Chris M. Reid, MD
author_sort Summer A. Beeson, BS
collection DOAJ
description Background:. Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed. Methods:. The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007–December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure. Results:. There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; P < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year (P < 0.01) but not at 5 years (P = 0.22). Conclusions:. This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients’ PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years.
first_indexed 2024-04-10T21:21:53Z
format Article
id doaj.art-8c0995a5d65240a381d36dd85586c43d
institution Directory Open Access Journal
issn 2169-7574
language English
last_indexed 2024-04-10T21:21:53Z
publishDate 2023-01-01
publisher Wolters Kluwer
record_format Article
series Plastic and Reconstructive Surgery, Global Open
spelling doaj.art-8c0995a5d65240a381d36dd85586c43d2023-01-20T02:34:50ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742023-01-01111e472710.1097/GOX.0000000000004727202301000-00017Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular DiseaseSummer A. Beeson, BS0Daniel Neubauer, MD1Richard Calvo, PhD2Michael Sise, MD3Matthew Martin, MD, FACS4David S. Kauvar, MD, MPH5Chris M. Reid, MD6From the * Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California San Diego, San Diego, Calif.† Department of Surgery, Naval Medical Center San Diego, San Diego, Calif.‡ Mercy Hospital Trauma Research Department, Scripps Mercy Hospital, San Diego, Calif.§ Department of Surgery, Trauma Surgery Service, Scripps Mercy Hospital, San Diego, Calif.§ Department of Surgery, Trauma Surgery Service, Scripps Mercy Hospital, San Diego, Calif.¶ Department of Surgery, Vascular Surgery Service, Brooke Army Medical Center, Fort Sam Houston, Tex.From the * Department of Surgery, Division of Plastic and Reconstructive Surgery, University of California San Diego, San Diego, Calif.Background:. Mortality rates following major lower extremity amputations (LEAs) 30 days–365 days postoperative have decreased, but 5-year rates remain high at 40.4%–70%. These data may not reflect recent advances in peripheral arterial disease (PAD) care, and comorbidities of chronic PAD may lead to mortality more frequently than the amputation itself. Mortality rates between diabetic and nondiabetic patients were also analyzed. Methods:. The California Office of Statewide Health Planning and Development hospital database was queried for patients admitted January 1, 2007–December 31, 2018. ICD-9-CM codes identified patients with vascular disease and an amputation procedure. Results:. There were 26,669 patients. The 30-day, 90-day, 1-year, and 5-year major LEA mortality rates were 4.82%, 8.62%, 12.47%, and 18.11%, respectively. Weighted averages of 30-day, 90-day, 1-year, and 5-year major LEA mortality rates in the literature are 13%, 15.40%, 47.93%, and 60.60%, respectively. Mortality risk associated with vascular disease after amputation (hazard ratio = 22.07) was 11 times greater than risk associated with amputation-specific complications from impaired mobility (hazard ratio = 1.90; P < 0.01). Having diabetes was associated with lower mortality at 30 days, 90 days, and 1 year (P < 0.01) but not at 5 years (P = 0.22). Conclusions:. This study suggests that people may be living longer after their major LEA than was previously thought. This study suggests that patients’ PAD may play a bigger role in contributing to their mortality than complications from loss of mobility postamputation. Although having diabetes was associated with lower postamputation mortality, the difference was no longer significant by 5 years.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004727
spellingShingle Summer A. Beeson, BS
Daniel Neubauer, MD
Richard Calvo, PhD
Michael Sise, MD
Matthew Martin, MD, FACS
David S. Kauvar, MD, MPH
Chris M. Reid, MD
Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
Plastic and Reconstructive Surgery, Global Open
title Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_full Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_fullStr Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_full_unstemmed Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_short Analysis of 5-year Mortality following Lower Extremity Amputation due to Vascular Disease
title_sort analysis of 5 year mortality following lower extremity amputation due to vascular disease
url http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004727
work_keys_str_mv AT summerabeesonbs analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT danielneubauermd analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT richardcalvophd analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT michaelsisemd analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT matthewmartinmdfacs analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT davidskauvarmdmph analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease
AT chrismreidmd analysisof5yearmortalityfollowinglowerextremityamputationduetovasculardisease